Health
AstraZeneca’s biologic combo AZD7442 for COVID-19 moving ahead – The Pharma Letter
AstraZeneca’s biologic combo AZD7442 for COVID-19 moving ahead
British scientists are trialling a new drug that could prevent people who have been exposed to the novel…To continue reading The Pharma Letter please login, subscribe or claim a 7 day free trial subscription and access exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space.
Or, if you’re only interested in reading the content about a specific topic (M&A, coronavirus/COVID-19, pricing, reimbursement and access, outsourcing,…
-
Noosa News18 hours agoWoman was watching keepers work when lion attacked, Darling Downs Zoo says
-
Noosa News17 hours agoWorking for someone else made it hard to care for my daughter. So I quit
-
General21 hours agoDeveloper warns wind energy capacity may not be ready by WA coal deadline
-
General14 hours agoQantas ‘contacted by potential cybercriminal’ after attack on data of up to 6 million customers